Delving into the Latest Updates on Shanxi Yanghe Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Otorhinolaryngologic Diseases

Nervous System Diseases

Congenital Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Infectious Diseases	1
Immune System Diseases	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

SCNA(Sodium voltage-gated channel alpha subunits)	1

To evaluate the pharmacokinetic characteristics of amisulpride in healthy Chinese volunteers after they were injected with three dose levels of amisulpride injection: 5mg/2mL, 7.5mg/3mL and 10mg/4mL; also to evaluate the safety of administering different doses of amisulpride injection to healthy Chinese volunteers.

Start Date-

Sponsor / Collaborator

Shanxi Yanghe Pharmaceutical Technology Co., Ltd.

[+1]

CTR20243863

/ Not yet recruitingPhase 3

评价氨磺必利注射液预防术后恶心呕吐的有效性和安全性的随机、双盲、安慰剂平行对照、多中心临床试验。

[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial to evaluate the efficacy and safety of amisulpride injection in preventing postoperative nausea and vomiting.

评价氨磺必利注射液预防术后恶心呕吐（PONV）的有效性和安全性。

[Translation]

To evaluate the efficacy and safety of amisulpride injection in preventing postoperative nausea and vomiting (PONV).

Start Date-

Sponsor / Collaborator

Shanxi Yanghe Pharmaceutical Technology Co., Ltd.

[+1]

CTR20221940

/ CompletedPhase 3

评价吸入用盐酸氨溴索溶液改善（成人）下呼吸道感染疾病粘痰症状的有效性和安全性的随机、双盲、安慰剂平行对照、多中心的临床研究

[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical study to evaluate the efficacy and safety of inhaled ambroxol hydrochloride solution in improving the symptoms of mucus in lower respiratory tract infections (adults)

评价山西阳和医药技术有限公司研制的吸入用盐酸氨溴索溶液改善（成人）下呼吸道感染疾病粘痰症状的有效性和安全性。

[Translation]

To evaluate the efficacy and safety of ambroxol hydrochloride solution for inhalation developed by Shanxi Yanghe Pharmaceutical Technology Co., Ltd. in improving the symptoms of sputum in lower respiratory tract infections (adults).

Start Date01 Sep 2022

Sponsor / Collaborator

Shanxi Yanghe Pharmaceutical Technology Co., Ltd.

[+1]

100 Clinical Results associated with Shanxi Yanghe Pharmaceutical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shanxi Yanghe Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Deals associated with Shanxi Yanghe Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shanxi Yanghe Pharmaceutical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3 Clinical

1

Login to view more data